Engineering Immunity: Modulating Dendritic Cell Subsets and Lymph Node Response to Direct Immune-polarization and Vaccine Efficacy

Overview

Journal J Control Release

Specialty Pharmacology

Date 2015 Oct 23

PMID 26489733

Citations 11

Authors

Jardin Leleux

Alexandra Atalis

Krishnendu Roy

Affiliations

Soon will be listed here.

Abstract

While successful vaccines have been developed against many pathogens, there are still many diseases and pathogenic infections that are highly evasive to current vaccination strategies. Thus, more sophisticated approaches to control the type and quality of vaccine-induced immune response must be developed. Dendritic cells (DCs) are the sentinels of the body and play a critical role in immune response generation and direction by bridging innate and adaptive immunity. It is now well recognized that DCs can be separated into many subgroups, each of which has a unique function. Better understanding of how various DC subsets, in lymphoid organs and in the periphery, can be targeted through controlled delivery; and how these subsets modulate and control the resulting immune response could greatly enhance our ability to develop new, effective vaccines against complex diseases. In this review, we provide an overview of DC subset biology and discuss current immunotherapeutic strategies that utilize DC targeting to modulate and control immune responses.

Citing Articles

Insights into vaccines for elderly individuals: from the impacts of immunosenescence to delivery strategies.

Hou Y, Chen M, Bian Y, Hu Y, Chuan J, Zhong L NPJ Vaccines. 2024; 9(1):77.

PMID: 38600250 PMC: 11006855. DOI: 10.1038/s41541-024-00874-4.

Advanced subunit vaccine delivery technologies: From vaccine cascade obstacles to design strategies.

Hou Y, Chen M, Bian Y, Zheng X, Tong R, Sun X Acta Pharm Sin B. 2023; 13(8):3321-3338.

PMID: 37655334 PMC: 10465871. DOI: 10.1016/j.apsb.2023.01.006.

Nanobiotics against antimicrobial resistance: harnessing the power of nanoscale materials and technologies.

Chakraborty N, Jha D, Roy I, Kumar P, Singh Gaurav S, Marimuthu K J Nanobiotechnology. 2022; 20(1):375.

PMID: 35953826 PMC: 9371964. DOI: 10.1186/s12951-022-01573-9.

Designing spatial and temporal control of vaccine responses.

Roth G, Picece V, Ou B, Luo W, Pulendran B, Appel E Nat Rev Mater. 2021; 7(3):174-195.

PMID: 34603749 PMC: 8477997. DOI: 10.1038/s41578-021-00372-2.

Targeting Dendritic Cells with Antigen-Delivering Antibodies for Amelioration of Autoimmunity in Animal Models of Multiple Sclerosis and Other Autoimmune Diseases.

Iberg C, Hawiger D Antibodies (Basel). 2020; 9(2).

PMID: 32549343 PMC: 7345927. DOI: 10.3390/antib9020023.

References

Caux C, Massacrier C, Vanbervliet B, Dubois B, Durand I, Cella M . CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis. Blood. 1997; 90(4):1458-70. View

Figdor C, van Kooyk Y, Adema G . C-type lectin receptors on dendritic cells and Langerhans cells. Nat Rev Immunol. 2002; 2(2):77-84. DOI: 10.1038/nri723. View

Chen W, Kawasaki N, Nycholat C, Han S, Pilotte J, Crocker P . Antigen delivery to macrophages using liposomal nanoparticles targeting sialoadhesin/CD169. PLoS One. 2012; 7(6):e39039. PMC: 3378521. DOI: 10.1371/journal.pone.0039039. View

Pradhan P, Qin H, Leleux J, Gwak D, Sakamaki I, Kwak L . The effect of combined IL10 siRNA and CpG ODN as pathogen-mimicking microparticles on Th1/Th2 cytokine balance in dendritic cells and protective immunity against B cell lymphoma. Biomaterials. 2014; 35(21):5491-504. PMC: 4747034. DOI: 10.1016/j.biomaterials.2014.03.039. View

Valladeau J, Clair-Moninot V, Dezutter-Dambuyant C, Pin J, Kissenpfennig A, Mattei M . Identification of mouse langerin/CD207 in Langerhans cells and some dendritic cells of lymphoid tissues. J Immunol. 2002; 168(2):782-92. DOI: 10.4049/jimmunol.168.2.782. View

Klechevsky E, Morita R, Liu M, Cao Y, Coquery S, Thompson-Snipes L . Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity. 2008; 29(3):497-510. PMC: 2688399. DOI: 10.1016/j.immuni.2008.07.013. View

Allenspach E, Lemos M, Porrett P, Turka L, Laufer T . Migratory and lymphoid-resident dendritic cells cooperate to efficiently prime naive CD4 T cells. Immunity. 2008; 29(5):795-806. PMC: 2746692. DOI: 10.1016/j.immuni.2008.08.013. View

Chang S, Ko H, Kweon M . Mucosal dendritic cells shape mucosal immunity. Exp Mol Med. 2014; 46:e84. PMC: 3972789. DOI: 10.1038/emm.2014.16. View

Waithman J, Zanker D, Xiao K, Oveissi S, Wylie B, Ng R . Resident CD8(+) and migratory CD103(+) dendritic cells control CD8 T cell immunity during acute influenza infection. PLoS One. 2013; 8(6):e66136. PMC: 3672151. DOI: 10.1371/journal.pone.0066136. View

10.

Santegoets S, Gibbs S, Kroeze K, van de Ven R, Scheper R, Borrebaeck C . Transcriptional profiling of human skin-resident Langerhans cells and CD1a+ dermal dendritic cells: differential activation states suggest distinct functions. J Leukoc Biol. 2008; 84(1):143-51. DOI: 10.1189/jlb.1107750. View

11.

Hornung V, Guenthner-Biller M, Bourquin C, Ablasser A, Schlee M, Uematsu S . Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med. 2005; 11(3):263-70. DOI: 10.1038/nm1191. View

12.

Stoitzner P, Schaffenrath S, Tripp C, Reider D, Komenda K, Del Frari B . Human skin dendritic cells can be targeted in situ by intradermal injection of antibodies against lectin receptors. Exp Dermatol. 2014; 23(12):909-15. PMC: 4282089. DOI: 10.1111/exd.12573. View

13.

Chen J, Pompano R, Santiago F, Maillat L, Sciammas R, Sun T . The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation. Biomaterials. 2013; 34(34):8776-85. PMC: 3814015. DOI: 10.1016/j.biomaterials.2013.07.063. View

14.

Kumamoto Y, Linehan M, Weinstein J, Laidlaw B, Craft J, Iwasaki A . CD301b⁺ dermal dendritic cells drive T helper 2 cell-mediated immunity. Immunity. 2013; 39(4):733-43. PMC: 3819035. DOI: 10.1016/j.immuni.2013.08.029. View

15.

Martin-Fontecha A, Sebastiani S, Hopken U, Uguccioni M, Lipp M, Lanzavecchia A . Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J Exp Med. 2003; 198(4):615-21. PMC: 2194169. DOI: 10.1084/jem.20030448. View

16.

Gerner M, Kastenmuller W, Ifrim I, Kabat J, Germain R . Histo-cytometry: a method for highly multiplex quantitative tissue imaging analysis applied to dendritic cell subset microanatomy in lymph nodes. Immunity. 2012; 37(2):364-76. PMC: 3514885. DOI: 10.1016/j.immuni.2012.07.011. View

17.

Angel C, George E, Brooks A, Ostrovsky L, Brown T, Dunbar P . Cutting edge: CD1a+ antigen-presenting cells in human dermis respond rapidly to CCR7 ligands. J Immunol. 2006; 176(10):5730-4. DOI: 10.4049/jimmunol.176.10.5730. View

18.

Singh A, Suri S, Roy K . In-situ crosslinking hydrogels for combinatorial delivery of chemokines and siRNA-DNA carrying microparticles to dendritic cells. Biomaterials. 2009; 30(28):5187-200. PMC: 2818033. DOI: 10.1016/j.biomaterials.2009.06.001. View

19.

Heath W, Carbone F . Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat Immunol. 2009; 10(12):1237-44. DOI: 10.1038/ni.1822. View

20.

Gilliet M, Liu Y . Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med. 2002; 195(6):695-704. PMC: 2193733. DOI: 10.1084/jem.20011603. View